# Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients

> **NCT00874289** · — · COMPLETED · sponsor: **The Alfred** · enrollment: 106 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** NGAL kit

## Key facts

- **NCT ID:** NCT00874289
- **Lead sponsor:** The Alfred
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2015-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00874289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00874289, "Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00874289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*